Evidence map›Paper›PMID 40046094›Full record

ArticleHealth science reports2025

In-Hospital Death and Risk Factors in Adults With Influenza in Spain (2016-2022): A Cross-Sectional Study With Focus on Older Patients.

Jose-Manuel Ramos-Rincon, Hector Pinargote-Celorio, Rosario Sanchez-Martinez, Juan-Carlos Rodríguez-Diaz, Silvia Otero, Fatima Valero-Sempere, Diego Torrús, Beatriz Valero-Novella, Geronima Riera, Vicente Boix and 1 more

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jose-Manuel Ramos-RinconClinical Medicine Department University Miguel Hernández of Elche Elche Spain.ORCID 0000-0002-6501-9867
Hector Pinargote-CelorioUnit of Infectious Diseases, Dr. Balmis General University Hospital Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID 0000-0002-3300-5807
Rosario Sanchez-MartinezClinical Medicine Department University Miguel Hernández of Elche Elche Spain.ORCID 0000-0003-3825-0198
Juan-Carlos Rodríguez-DiazClinical Medicine Department University Miguel Hernández of Elche Elche Spain.ORCID 0000-0001-8007-5739
Silvia OteroUnit of Infectious Diseases, Dr. Balmis General University Hospital Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID 0000-0002-7801-5072
Fatima Valero-SempereInternal Medicine Department, Dr. Balmis General University Hospital Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID 0000-0002-0921-1854
Diego TorrúsUnit of Infectious Diseases, Dr. Balmis General University Hospital Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.ORCID 0000-0002-5694-8162
Beatriz Valero-NovellaInternal Medicine Department, Dr. Balmis General University Hospital Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.
Geronima RieraPharmacy Department, Dr. Balmis General University Hospital Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain.
Vicente BoixClinical Medicine Department University Miguel Hernández of Elche Elche Spain.ORCID 0000-0002-7015-3948
Esperanza MerinoClinical Medicine Department University Miguel Hernández of Elche Elche Spain.ORCID 0000-0003-3854-4874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Influenza mortality rates varying across different populations. This study aims to assess influenza lethality in hospitalized adults (≥ 15 years) and identify key risk factors according to age. Methods: We designed a retrospective study at Dr. Balmis General University Hospital (Alicante, Spain), including patients hospitalized for influenza from 2016 to 2022. In-hospital death was expressed as the case fatality rate (CFR). Variables yielding a Results: Of 1613 patients admitted for influenza (incidence 86 per 10,000 admissions), 96 died (CFR 5.95%). Lethality increased with age, reaching 8.4% in patients aged 80-89 years and 19.5% in those over 90. In all of the cohort, risk factors were age, dementia, respiratory failure, influenza pneumonia, and sepsis, while treatment with oseltamivir acted as a protective factor. In patients < 80 years of age, risk factors were neoplasia, respiratory failure, and influenza pneumonia, whereas oseltamivir treatment was a protective factor. In patients 80 years ( Conclusion: Influenza deaths increase with age; this relationship is accentuated in people aged 80 or older. Respiratory failure was the main risk factor in all patients hospitalized for influenza. Treatment with oseltamivir protected patients (especially those < 80 years) against deaths. Patients < 80 years-old carried a higher risk of death if they had a neoplasia, whereas in ≥ 80 patients, the risk was associated with dementia and noninfluenza pneumonia.

Indexed as

agedinfluenzamortalityover 80 and olderrespiratory insufficiency

Identifiers

PMID40046094
PMCPMC11879891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.